TearLab Corp 4
4 · TearLab Corp · Filed Oct 15, 2013
Insider Transaction Report
Form 4
TearLab CorpTEAR
Karpecki Paul
Director
Transactions
- Exercise/Conversion
Common Stock
2013-10-11$3.12/sh+5,000$15,600→ 8,500 total - Sale
Common Stock
2013-10-11$10.96/sh−5,000$54,819→ 3,500 total - Exercise/Conversion
Stock Option (right to buy)
2013-10-11−5,000→ 3,376 totalExercise: $3.12Exp: 2018-12-12→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013.
- [F2]Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $10.905 to $11.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months.